This Article Full Text Full Text (PDF) All Versions of this Article: 117/21/2743    most recent CIRCULATIONAHA.107.750232v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Pattison, J. S. Articles by Robbins, J. Search for Related Content PubMed PubMed Citation Articles by Pattison, J. S. Articles by Robbins, J. Related Collections Apoptosis Genetically altered mice Heart failure - basic studies Related Article

(Circulation. 2008;117:2743-2751.)
© 2008 American Heart Association, Inc.

Heart Failure

Cardiomyocyte Expression of a Polyglutamine Preamyloid Oligomer Causes Heart Failure

J. Scott Pattison, PhD; Atsushi Sanbe, PhD; Alina Maloyan, PhD; Hanna Osinska, PhD; Raisa Klevitsky, MD; Jeffrey Robbins, PhD

From the Department of Pediatrics, Division of Molecular Cardiovascular Biology, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio.

Correspondence to Jeffrey Robbins, Cincinnati Children’s Hospital Medical Center, MLC 7020, 3333 Burnet Ave, Cincinnati, OH 45229. E-mail jeff.robbins{at}cchmc.org

Received November 8, 2007; accepted March 24, 2008.

Background— To determine whether soluble preamyloid oligomers (PAOs) are toxic when expressed internally in the cardiomyocyte, we tested the hypothesis that cardiomyocyte-restricted expression and accumulation of a known PAO is cytotoxic and sufficient to cause heart failure.

Methods and Results— Intracellular PAOs, the entities believed to cause toxicity in many neurodegenerative diseases, have been observed in cardiomyocytes derived from mouse and human heart failure samples. Long (>50) polyglutamine (PQ) repeats form PAOs and cause neurotoxicity in Huntington disease and other neurodegenerative diseases, whereas shorter PQ peptides are benign. We created transgenic mice in which cardiomyocyte-autonomous expression of an 83 residue–long PQ repeat (PQ83) or a non–amyloid-forming peptide of 19 PQ repeats (PQ19) as a nonpathological control was expressed. A PQ83 line with relatively low levels of expression was generated, along with a PQ19 line that expressed 9-fold the levels observed in the PQ83 line. Hearts expressing PQ83 exhibited reduced cardiac function and dilation by 5 months, and all mice died by 8 months, whereas PQ19 mice had normal cardiac function, morphology, and life span. PQ83 protein accumulated within aggresomes with PAO-specific staining. The PQ83 hearts showed increased autophagosomal and lysosomal content but also showed markers of necrotic death, including inflammatory cell infiltration and increased sarcolemmal permeability.

Conclusions— The data confirm the hypothesis that expression of an exogenous PAO-forming peptide is toxic to cardiomyocytes and is sufficient to cause cardiomyocyte loss and heart failure in a murine model.

---

 

CLINICAL PERSPECTIVE

Related Article:

Clinical Summaries
Circulation 2008 117: 2719-2720. [Extract] [Full Text]